Company Filing History:
Years Active: 2025
Title: Hahnsun Jung: Innovator in Mitochondrial Therapeutics
Introduction
Hahnsun Jung is a prominent inventor based in Gunpo-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic compositions. His work focuses on enhancing the safety and efficacy of mitochondrial treatments.
Latest Patents
Hahnsun Jung holds a patent for an "Injection composition containing isolated mitochondria, and use thereof." This patent describes a liquid composition for injection that includes glycine, saccharide, buffer, and isolated mitochondria. The composition is designed to secure the safety of mitochondrial therapies while maintaining mitochondrial activity. It aims to prevent and treat diseases related to mitochondrial dysfunction and inhibit blood clot formation in patients.
Career Highlights
Jung is associated with Paean Biotechnology Inc., where he continues to advance research in mitochondrial therapeutics. His innovative approach has the potential to revolutionize treatments for various diseases caused by mitochondrial dysfunction.
Collaborations
Hahnsun Jung collaborates with notable colleagues, including Young-Cheol Kang and Kyuboem Han. Their combined expertise contributes to the ongoing development of cutting-edge biotechnological solutions.
Conclusion
Hahnsun Jung's work in mitochondrial therapeutics exemplifies the impact of innovation in biotechnology. His contributions are paving the way for safer and more effective treatments for mitochondrial-related diseases.